Dr. Melton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 16th St 434
San Francisco, CA 94158Phone+1 415-476-3831Fax+1 415-353-2765
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2012 - 2015
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2009 - 2012
- University of Texas Southwestern Medical SchoolClass of 2009
Certifications & Licensure
- CA State Medical License 2011 - 2025
- TX State Medical License 2018 - 2018
- MA State Medical License 2009 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 8 citationsReduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants.Cristina F. Contreras, Janel Long-Boyle, Kristin A. Shimano, Alexis Melton, Sandhya Kharbanda
Biology of Blood and Marrow Transplantation. 2020-09-01 - 22 citationsLow Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency.Christopher C. Dvorak, Janel Long-Boyle, Jasmeen Dara, Alexis Melton, Kristin A. Shimano
Biology of Blood and Marrow Transplantation. 2019-07-01 - 62 citationsCombinatorial Control of Signal-Induced Exon Repression by hnRNP L and PSFAlexis Melton, Jason Jackson, Jiarong Wang, Kristen W. Lynch
Molecular and Cellular Biology. 2007-10-01
Abstracts/Posters
- Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell TransplantsAlexis Melton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic LymphohistiocytosisAlexis Melton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Final Four ‘Wish’ Granted to Young Survivor of Rare Immune DiseaseApril 4th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: